Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Cystic Fibrosis Related Diabetes (CFRD)
- People aged between 21 and 75 years old at the time of signing the consent form
- People with a body mass index (a measure of body weight relative to height) between 19 and 50, or between 17 and 48 for people of Asian background
- People whose kidneys are functioning within certain levels, based on a blood marker called creatinine (below 1.4 for women and 1.5 for men — confirm with trial site)
- People whose blood sugar levels over the past few months (measured by a test called HbA1c) are at or below 11%, whether managed through lifestyle, tablets, or insulin (including insulin pumps or multiple daily injections)
- People who are taking a cystic fibrosis medication called ETI (elexacaftor/tezacaftor/ivacaftor) at the full dose approved by the FDA
- People who are willing to keep their weight stable for the whole duration of the study
- People who understand the study requirements and are willing to follow the study plan and sign the consent form
Who may not be able to join:
- People who have a severe or debilitating long-term illness (other than the condition being studied)
- People with low red blood cell levels (anaemia) — below a certain level in both men and women (confirm with trial site)
- People who have unexplained symptoms of an undiagnosed illness at the time of joining
- People who currently misuse alcohol or recreational drugs
- People who are pregnant
- People with active liver disease or significant liver scarring (people with only mildly elevated liver readings may still be considered — confirm with trial site)
- People currently taking any of the following medications: corticosteroids (such as prednisone), benzodiazepines (such as diazepam), opioid pain medicines, barbiturates, blood thinners (anticoagulants), or any other medication the trial doctor considers to be a safety concern
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rita Basu, MD, UAB Medicine
Phone: 205-934-1200
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disposition Index in CFRD
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.